Metacarpal prosthesis
Access comprehensive regulatory information for Metacarpal prosthesis in the Australia medical device market through Pure Global AI's free TGA ARTG database. This Class IIb is sponsored by LC & Partners Pty Ltd, manufactured by Groupe Lepine in France. The device registration started on May 02, 2024.
This page provides complete registration details including sponsor information, manufacturer details, and regulatory compliance data from the official Australia TGA ARTG medical device database. Pure Global AI offers free access to Australia's complete medical device registry with 131,000+ devices, helping global MedTech companies navigate TGA regulations efficiently.
- This implant has been developed and manufactured to restore function to the trapeziometacarpal joint. - The expected clinical benefits for patients are pain relief, restoration of mobility and restoration of function. - The durability and quality of the implantation depends on its environment, its implantation conditions and how it is used. - For maximum performance and durability of the implant, recommended associations described in our documentation system must be followed. - The expected lifetime of this implant is 10 years